NLSP   $5.3  5.16% Market Closed

NLS Pharmaceutics AG
Total Cash 897.68K
totalCashPerShare 0.894
EBITDA -11.80M
Total Debt 1.63M
quickRatio 0.118
currentRatio 0.23
Total Revenue
debtToEquity
Revenue/Share
ROA -1.32684
ROE
grossProfits
freeCashflow -5.00M
operatingCashflow -9.68M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 5.52M
forwardPE
floatShares 527.31K
sharesOutstanding 1.17M
sharesShort 40.07K
sharesShortPriorMonth 29.65K
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.18%
heldPercentInstitutions 0.26%
Short Ratio help_outline 1.70%
shortPercentOfFloat 0.05%
impliedSharesOutstanding
bookValue -10.896
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -12.17M
trailingEps -12.80%
forwardEps -0.55%
enterpriseToEbitda -0.47
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 11
lastUpdated Oct. 16, 2024, 11:48 p.m.